What Your CGM Data Really Says: New Research Reveals Seven Distinct Glucose Patterns in Type 1 Diabetes

Continuous glucose monitoring has transformed how people with Type 1 diabetes track and manage their blood sugar. But the flood of data from a CGM can feel overwhelming, and your glucose patterns might look very different from someone else's—even if you both have Type 1 diabetes. A new study published in Frontiers in Endocrinology took a closer look at how to use all that CGM information more intelligently.

Researchers analyzed CGM data from 75 people living with Type 1 diabetes and 20 people without diabetes, using advanced clustering methods to identify patterns in glucose levels and variability. The goal was simple but important: understand what different CGM patterns actually mean for individual management and insulin sensitivity.

The analysis revealed seven clinically distinct glucose profiles, each telling a different story about how someone's body is handling glucose and insulin:

Three profiles showed relatively stable patterns: Normoglycemia-in-Diabetes (people with T1D maintaining near-normal glucose), Normoglycemia-in-Non-Diabetes (the comparison group without diabetes), and Hypoglycemia-Associated Normoglycemia (people who experience lows but maintain normal average readings). Three others showed hyperglycemia: Mild, Moderate, and Severe Hyperglycemia, with Severe Hyperglycemia showing the highest average glucose levels at 13.83 mmol/L (about 249 mg/dL). A seventh profile, Hypoglycemia-Associated Hyperglycemia, stood out for extreme glucose variability—the highest swings between lows and highs.

Each profile represents a different management challenge and may require different approaches to insulin dosing, timing, or lifestyle adjustments.

One of the study's key findings was a connection between certain CGM patterns and how efficiently the body uses insulin. Researchers calculated an estimated glucose disposal rate (eGDR)—a measure of insulin sensitivity—and compared it across the different clusters.

Significant differences in insulin sensitivity were found between specific groups: notably, the Hypoglycemia-Associated Normoglycemia group showed different insulin sensitivity compared to those in the Severe, Moderate, and Mild Hyperglycemia groups. While the differences were statistically meaningful, the researchers noted that other markers needed further investigation to fully understand these relationships.

This suggests that CGM patterns alone can hint at how your body is responding to insulin, but the full picture involves multiple factors working together.

The practical value of this research lies in personalization. Not everyone with Type 1 diabetes manages the same way, and one-size-fits-all recommendations often fall short. By identifying seven distinct CGM phenotypes, researchers are laying groundwork for more targeted management strategies based on what your actual data shows.

If your glucose pattern matches one of these profiles, it could eventually help your healthcare team fine-tune your insulin regimen, identify whether insulin resistance is playing a role, or spot patterns that suggest lifestyle or medication adjustments might help. The study opens the door to using CGM data not just to see what's happening, but to understand why—and what to do about it.

This is early-stage research, and more work is needed to translate these findings into clinical recommendations. But it represents progress toward making CGM data work harder for you.

Source: Frontiers in endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.